Metalens Technology Expected to Reach Commercial Market in 2022 - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Metalens Technology Expected to Reach Commercial Market in 2022

    Article obtained from Photonics RSS Feed.

    Metalenz, the Harvard University-originating startup that last week received exclusive license to flat-optics innovations developed in the lab of Federico Capasso, said that the long-awaited metalens technology will likely see introduction into the commercial market as early as next year. Rob Devlin, CEO and co-founder of Metalenz, told Photonics Media that he expects the company to ship its first consumer device in early 2022.

    Metalenz is not yet naming a partner, though the company has engaged with a number of Tier 1 OEMs, Devlin said. He expects to begin shipping the lenses at the end of 2021, which are expected to be released in the commercial market by the first quarter of 2022.

    The technology, which manipulates light at…

    READ MORE
    Feb, 09 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.